Highly Profitable Medical Sales & Consulting Organization Based in the Midwest

American HealthCare Capital is pleased to exclusively introduce a highly profitable medical sales and consulting company for sale in the Midwest. Founded in 2018, the company partners with leading manufacturers and suppliers of regenerative biologics and wound care products, serving as a dedicated outsourced salesforce. It focuses on sales, case coverage, and clinical consulting while suppliers handle all billing and collections.

The company operates with exceptional efficiency and profitability. Its client base includes wound care centers, mobile wound care providers, podiatry practices, and private outpatient clinics. By providing subject-matter expertise, clinical oversight, and staff training—not just pricing—the company has created long-term, sticky client relationships.

The Current Market

The regenerative biologics market is undergoing a major transition, with providers expected to concentrate purchasing on products backed by strong clinical evidence. Beginning in January 2026, new Medicare rules will narrow the range of products that clinics are willing and able to adopt, which is likely to reduce overall sales volumes and pressure many competitors. The company’s asset-light, commission-based model is well positioned to adapt quickly, capture additional demand, and expand its market share as sales consolidate around fewer, clinically validated products.

Financial Overview

The company has experienced rapid growth in recent years, with revenue increasing from $4.2 million in 2023 to $8.3 million in 2024, and over $9.1 million in 2025 through June, putting them on track to exceed $18.2 million by the end of year. EBITDA has doubled annually and is expected to reach over $16 million in 2025. With industry shifts expected in 2026, management anticipates revenue in the $6–$8 million range and EBITDA of approximately $4–$5 million under the new payment environment. Despite these shifts, the company is strategically aligned with manufacturers whose products meet the latest clinical and reimbursement standards, ensuring continuity and positioning it for growth.

Staffing Overview

The company is supported by a lean team of salespeople who are expected to remain with the business following a transition. The owner is committed to assisting with a six- to twelve-month transition post-sale to ensure continuity with clients, suppliers, and staff.

Asking Price

The asking price for this opportunity is $30 million, which does not include cash, receivables, or working capital.

Rare $11.0 Million EBITDA Orthotics & Prosthetics Company in a Federally Protected Market

American Healthcare Capital is proud to be the exclusive representative of a rare opportunity to acquire a highly specialized medical services Orthotics & Prosthetics Company with distribution platform serving a defensible, federally protected market niche. With a unique presence embedded on secured government sites across the United States and a growing international footprint, the Company has become a recognized leader in providing orthopedic bracing, medical devices, and durable medical equipment (DME) to a highly underserved yet critical population.

The business has experienced strong financial performance with double-digit EBITDA margins and is projecting exponential revenue and profit growth in 2026 due to opening of new centers as well as a strategic acquisition made in late 2025, that will be contributing additional $4 Million to their net adjusted EBITDA for 2026. With exclusive partnerships, regulatory certifications, and government contracting opportunities already in motion, the Company is positioned for scalable, sustainable growth across military, government, and private healthcare channels.

Highlights

Deeply Embedded, High-Barrier Market Access: Operating on secured government sites with exclusive access to federal personnel and their dependents.

Established Clinical Network: Locations strategically positioned in key U.S. regions with planned expansions underway.

Exclusive Product Partnerships: Long-term national partnerships with leading medical device and orthotics manufacturers.

Government Contracting Pipeline: GSA and VA contract applications filed with expected award notifications by mid-year.

Private Market Expansion: Recent certifications with regional and national health plans unlocking access to civilian healthcare markets.

International Expansion: Active international deployment on secured government sites outside the U.S.

Scalable Platform with Strong Leadership: Highly capable and experienced management team committed to staying on and rolling equity to support the next phase of growth.

2022202320242025-Proj. Est.2026Revenue$15,141,192$18,028,775$16,439,879$18,500,000$26,000,000EBITDA$3,466,207$4,883,034$4,055,969$4,500,000$11,000,000Margin %23%27%25%24%42%

Financial Snapshot

*2026 Revenue and EBITDA include the new acquisition of the supply chain in Q4 of 2025

The leadership team is confident that the pipeline of new expansions, private market certifications, product launches, and government approvals will fuel double-digit revenue and EBITDA growth in the coming years.

Investment Thesis

The Company’s exclusive market positioning, proven financial performance, and clear runway for expansion make this an ideal platform for investors or strategic acquirers seeking a defensible foothold in government healthcare, with immediate opportunities to scale nationally and internationally.

The owners are seeking a capital or strategic partner to accelerate growth through geographic expansion, onsite government contracting, and private market penetration, with leadership committed to remaining actively involved.

Asking Price

The asking price and valuation for the company shall be determined based on discussion and negotiation. The current leadership team is open to a majority equity sale, rollover equity, or an earn out that can help them accelerate growth and capture additional market share. The final asking price will exclude, Cash, Accounts Receivables, Working Capital, and Real-estate holdings.

$27 Million Revenue, Multi-Location Dental Support Organization

American Healthcare Capital is pleased to present an opportunity to acquire a well-established Dental Support Organization (DSO) operating across 12 locations throughout several major U.S. markets. With a large and experienced network of providers, this DSO provides a comprehensive range of dental services, including hygiene (25-35%), restorative care (15-20%), and crowns (15-20%), alongside a variety of specialties available at each location.

Financial Overview

The company’s current payer mix is approximately 55% Commercial Insurance and 45% Private Pay. Over the past few years, the company has shown consistent growth. In 2022, the company collected $22,557,101 in gross annual revenue with an adjusted EBITDA of $6,936,792. In 2023, revenue increased by approximately 17%, with collections totaling $27,617,033 and an adjusted EBITDA of $6,893,139. In 2024, they collected $27,196,895 in gross revenue with an adjusted EBITDA of $6,483,735.

Growth Opportunities

This DSO has significant potential for further expansion, with growth opportunities in extending service hours (weekends and evenings) and negotiating higher insurance rates. Supported by a talented, experienced management team, the organization is positioned as a market leader with a strong referral network and operational efficiency. This acquisition is ideal for a buyer seeking to enter or expand within the dental sector with an established, high-performing multi-location DSO in a major U.S. market.

Strategic Buyer Fit

This opportunity is being specifically positioned for a strategic buyer with an existing dental support organization platform. The business is best suited for an acquirer that can leverage its established infrastructure to integrate operations efficiently and maximize profitability. With a scalable model, a strong provider network, and a well-defined referral base, this acquisition presents an ideal expansion opportunity for a DSO looking to enhance its market presence and accelerate growth through operational synergies.

Staff Overview

The staff is expected to stay on under new ownership. The owner is open to remaining for a brief transition period to ensure a smooth handover.

Asking Price

The asking price for this opportunity is $40 million.

Highly Profitable DME/HME Company with Multiple Locations on Military/Army Bases Throughout the US, Europe, and Asia

American HealthCare Capital is pleased to introduce a DME/HME company for sale with multiple locations throughout the US, Europe and Asia. The company was established over 25 years ago. Most of their locations are on army bases in 7 USA states. Within Europe and Asia there are an additional 17 military bases. This company services DME in a total of 34 military base locations.

The company has virtually no competitors within the Army bases. Their primary payer is Tricare. Under our current government administration, further growth is anticipated due to potential expansion of Tricare for the army on bases.

Financial Overview

The breakdown of revenue by product is as follows: 64% CPAP, 17% Breast and Maternity needs, 11% Mobility Needs, 7% Compression needs, and 3%-5% Home Care needs. There is a new highly profitable cash sale of power Mobility and Lift Chairs in 2025.

The company’s DME gross revenue for 2023 was $34.8 million with an EBITDA of $2 million. The Revenue for 2024 was $38 million with an EBITDA of $2.03 million. The projected 2025 revenue is $28 Million and EBITDA between $2.5 Million and $5.5 Million dollars.

Approximately 90% of their highly profitable business is from Tricare with a very small amount of Medicare. If a new owner were to focus on additional payers, and doing Delivery, revenue and profit could increase as well.

Staff Overview

The company president, operator, and administrator will stay to advise the company for the buyer needs.

Asking Price

The asking price for this opportunity is To Be Determined and will include $10 million in tangible assets: accounts receivables, inventory, and real estate. In addition, there will be a major soon increase in revenues with amazing profits in their new healthcare services to an additional 100 Military Bases starting next year.